← Back to the Areas of Interest
Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
View the full invitation
Servier - Can current treatment strategies for mCRC be further optimized?
Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
Ipsen - The today and tomorrow of systemic treatment for HCC
Merck KGaA - From complexity to clarity: Optimizing the mCRC continuum of care (Medical)
Incyte Biosciences International Sàrl - Patient centricity in cholangiocarcinoma: A multidisciplinary discussion
F. Hoffmann-La Roche Ltd. - Integrating cancer immunotherapy combinations into HCC practice: Duos, data and decisions
AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Programme and Faculty are preliminary and subject to change.
© 2019 cSLIDE CTI MEETING TECHNOLOGY. All rights reserved.